
A group of 9 experts reflect on what they are looking forward to most in 2025 following the AAD annual meeting.
Robert Snyder, MD, is board-certified in dermatology and internal medicine, currently with Riverchase Dermatology.

A group of 9 experts reflect on what they are looking forward to most in 2025 following the AAD annual meeting.

This interview with Snyder features a discussion on recent findings on remibrutinib among patients with chronic spontaneous urticaria, also known as CSU.